Mitropoulos Dionisios, Kiroudi Aspasia, Christelli Evangelia, Serafetinidis Efraim, Zervas Anastasios, Anastasiou Ioannis, Dimopoulos Constantinos
Department of Urology, University of Athens Medical School, 75 Mikras Asias St., 115-27 Athens, Greece.
Urol Res. 2004 Oct;32(5):317-22. doi: 10.1007/s00240-003-0360-z. Epub 2004 Sep 7.
TGFbeta1 is one of several cytokines produced by proximal tubular and renal cancer cells. Previous studies have been mainly focused on determining plasma or serum TGFbeta levels, its effect on RCC cultures, and the expression of TGFbeta mRNA. Cancerous and autologous normal kidney samples were obtained from 24 patients treated by radical nephrectomy. TGFbeta1 expression was determined using a semi quantitative Western blot analysis and immunohistochemistry. Blot densities and immunohistochemical expression intensities in normal and neoplastic tissue were compared, and subsequently correlated to tumor stage, histological type and nuclear grade. All tissue samples examined expressed TGFbeta1; mean tumor to non-involved kidney spot density ratio correlated with advancing stage and higher nuclear grade. The overexpression of TGFbeta1 in certain RCCs may partially explain their resistance to the growth suppression action of TGFbeta. The correlation with tumor stage and grade indicates a possible role in the development of metastatic potential as well as in host's immune response modulation.
转化生长因子β1(TGFbeta1)是近端肾小管细胞和肾癌细胞产生的几种细胞因子之一。以往的研究主要集中在测定血浆或血清中TGFbeta水平、其对肾细胞癌(RCC)培养物的影响以及TGFbeta mRNA的表达。从24例接受根治性肾切除术的患者中获取癌组织和自体正常肾组织样本。使用半定量蛋白质免疫印迹分析和免疫组织化学法测定TGFbeta1的表达。比较正常组织和肿瘤组织中的印迹密度和免疫组化表达强度,随后将其与肿瘤分期、组织学类型和核分级相关联。所有检测的组织样本均表达TGFbeta1;平均肿瘤与未受累肾脏的斑点密度比值与疾病进展期和更高的核分级相关。TGFbeta1在某些肾细胞癌中的过表达可能部分解释了它们对TGFbeta生长抑制作用的抗性。与肿瘤分期和分级的相关性表明其在转移潜能发展以及宿主免疫反应调节中可能发挥作用。